HCC Conclusions (2)
Recent NIRS data suggest unique solu3ons
Large tumor size (≠ PEI, RFA, SBRT)
Loca3on at porta hepa3s (≠ PEI, RFA, surgery)
Cost: 2 frac3ons
Range of applica3on with cura3ve intent
Inoperable or unable to support invasive procedures
Range of size and numbers of tumors
Unresectable disease
HCC near porta hepa3s
Pa3ents on the transplant list
Trials
Hypofrac3onated PBT
Randomized trials against ‘standards’